FibroBiologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.83	9.16	2.27	0.41	-
Cash & Short-Term Investments	7.83	9.16	2.27	0.41	-
Cash Growth	-27.30%	304.37%	456.76%	-	-
Receivables	-	-	0.3	-	-
Prepaid Expenses	0.35	0.04	0.03	0.04	-
Other Current Assets	0.02	0.02	0.03	0.02	-
Total Current Assets	8.2	9.22	2.63	0.47	-
Property, Plant & Equipment	2.27	2.61	2.2	-	-
Total Assets	10.47	11.82	4.82	0.47	-
Accounts Payable	1.18	1.44	0.76	0.23	-
Short-Term Debt	0.12	-	5.45	1.53	-
Current Portion of Leases	0.39	0.36	0.33	-	-
Other Current Liabilities	4.99	7.38	0.54	-	-
Total Current Liabilities	6.68	9.18	7.07	1.76	-
Long-Term Leases	1.06	1.39	1.75	-	-
Total Liabilities	7.73	10.57	8.82	1.76	-
Common Stock	-	0	0	-	1.17
Additional Paid-In Capital	35.16	25.61	2.41	-	-
Retained Earnings	-32.42	-24.36	-7.87	-2.75	-1.17
Comprehensive Income & Other	-	-	1.46	1.46	-
Shareholders' Equity	2.74	1.25	-4	-1.29	-
Total Liabilities & Equity	10.47	11.82	4.82	0.47	-
Total Debt	1.56	1.75	7.52	1.53	-
Net Cash (Debt)	6.27	7.42	-5.26	-1.12	-
Net Cash Per Share	0.20	0.26	-0.19	-0.13	-
Filing Date Shares Outstanding	34.66	32.49	28.23	40.73	8.75
Total Common Shares Outstanding	33.92	28.23	28.23	40.73	8.75
Working Capital	1.52	0.03	-4.45	-1.29	-
Book Value Per Share	0.08	0.04	-0.14	-0.03	-
Tangible Book Value	2.74	1.25	-4	-1.29	-
Tangible Book Value Per Share	0.08	0.04	-0.14	-0.03	-
Machinery	0.93	0.84	-	-	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q